How long does it take for upadatinib to be effective in treating atopic dermatitis? How to take medicine?

Atopic dermatitis, a chronic skin disease known for its recurring inflammation, unbearable itching, and dry and flaky skin, brings physical and mental challenges to patients. For patients 12 years of age and older with refractory moderate to severe atopic dermatitis, when other systemic drugs are ineffective or inapplicable, upadatinib has attracted increasing attention as an emerging treatment method. So, how long does it usually take for patients to see effects after using upadacitinib? How to take it correctly?

There is no fixed answer to the time it takes for upadacitinib to be effective in treating atopic dermatitis. It depends on the severity of the patient's condition, the individual's response to the medication, and many factors during treatment. Some patients may feel significant relief of symptoms after only one week of medication, while most patients may need 12 weeks of treatment to see significant improvement. If the condition is effectively controlled and no serious side effects occur, the doctor may gradually reduce the dosage of the drug based on the patient's specific condition until the drug is finally discontinued. But importantly, upadatinib does not cure atopic dermatitis; its main function is to control symptoms. Therefore, patients still need to pay attention after stopping the drug, as there is a certain risk of recurrence. Medication time and dosage adjustments during the entire treatment process should be carried out under the guidance of a doctor.

As for the dosage of upadatinib, according to the instructions, the starting dose is usually 15 mg orally once daily. This dose is suitable for pediatric patients 12 years of age and older and weighing at least 40 kilograms, and adults under 65 years of age. If the patient fails to see significant effects within a few weeks of taking the medication, the doctor may recommend increasing the dose to 30 mg orally once daily to help the patient relieve symptoms faster. Discontinue if adequate response is not achieved with the 30 mg dose. Use the lowest effective dose needed to maintain response. For seniors aged 65 and above, for safety reasons, the recommended dose is still 15 mg orally once daily.

In addition, for patients with severe renal impairment, the recommended dose of upadatinib is 15 mg orally once daily, and throughout the treatment period, patients need regular liver and kidney function monitoring to ensure the safety of the medication. At the same time, good living habits and dietary adjustments can provide assistance in the management of the disease, such as avoiding irritating foods and keeping the skin moisturized.

In general, the treatment of atopic dermatitis with upadatinib needs to follow the principle of individualization. Medication time and dosage need to be flexibly adjusted by doctors according to the patient's specific conditions. Patients should strictly follow medical instructions and use medications rationally in order to effectively control symptoms, reduce the risk of recurrence, and improve quality of life.

References:

https://www.drugs.com/rinvoq.html